Sabrina Chan
Sabrina is an emerging researcher in Women’s Neurology. Her research integrates epidemiology and mixed-methods approaches to generate meaningful data that informs healthcare practice and drives the future of medical education.
Under the supervision of Dr. Esther Bui, founder of Canada’s first and only Women’s Neurology Program at the University of Toronto, Sabrina currently leads a North American AED Pregnancy Registry (NAAPR) study on the antiseizure medication use in women with epilepsy.
Vision & Values
Grounded in gratitude for those who paved the way, Sabrina strives to build upon this legacy and continue to advance humanity by transforming clinical insights into meaningful science.
Sabrina values balance and integration. In research, she combines rigor with creativity; in patient care, she pairs compassion with professionalism. In life, she balances between heart and science.
Portfolio
From the Centre for Addiction & Mental Health (CAMH), to the University Health Network (UHN), Sabrina has extensive clinical experience that demonstrates both scope and depth.
-
Treatment coordination and clinical trial recruitment for children and youth in out-patient and community psychiatry treatments.
-
Quantitative, qualitative, and epidemiology research on neurological and obstetrical outcomes in antiseizure medication use and non-pharmacological interventions.
-
Advancement of interdisciplinary collaborations among institutional leaders in national consensus, medical education curriculum, and knowledge translation.
